NCT04285788已完成不适用
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogeneic Hematopoietic Cell Transplant Recipients: AdVance
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Chimerix
- 入组人数
- 216
- 主要终点
- Number of participants with non-relapse related mortality 3 and 6 months after first AdV Virema in paediatric allo-HCT recipients
研究概览
简要总结
To depict the incidence, outcomes and standards of care (SoC) of adenovirus (AdV) infections and associated practice patterns in allogeneic hematopoietic cell transplant recipients. It is expected that participating centers will be in the United Kingdom, France, Spain, Germany, and Italy.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 0 Months 至 90 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least one AdV positive test, regardless of specimen within 6 months following the first allo-HCT
- •Subjects first allo-HCT must have been performed between 1 January 2013 and 30 September 2015
排除标准
- •AdV negative
结局指标
主要结局
Number of participants with non-relapse related mortality 3 and 6 months after first AdV Virema in paediatric allo-HCT recipients
时间窗: 3 and 6 months after first adenovirus viremia
To assess non-relapse related mortality 3 to 6 months after first adenovirus viremia.
次要结局
- The rate of adenovirus infection progression(3 to 6 months)
- Number of participants who were hospitalized To assess the number of hospitalizations(3 to 6 months)
研究者
相似试验
已完成
不适用
ADenoVirus Initiative Study in Epidemiology in GermanyViral ConjunctivitisNCT02054273NicOx240
已完成
不适用
ADenoVirus Initiative Study in Epidemiology in UKViral ConjunctivitisNCT02112773NicOx31
已完成
不适用
ADenoVirus Initiative Study in Epidemiology in SpainViral ConjunctivitisNCT02254330NicOx386
已完成
不适用
ADenoVirus Initiative Study in Epidemiology in FranceViral ConjunctivitisNCT02054234NicOx357
已完成
不适用
ADenoVirus Initiative Study in Epidemiology in ItalyViral ConjunctivitisNCT03055065NicOx241